Northern Trust Corp Mainz Biomed N.V. Transaction History
Northern Trust Corp
- $600 Billion
- Q3 2024
A detailed history of Northern Trust Corp transactions in Mainz Biomed N.V. stock. As of the latest transaction made, Northern Trust Corp holds 29,934 shares of MYNZ stock, worth $141,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,934
Previous 29,934
-0.0%
Holding current value
$141,587
Previous $11,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MYNZ
# of Institutions
12Shares Held
191KCall Options Held
0Put Options Held
0-
Vontobel Holding Ltd.45KShares$212,8500.0% of portfolio
-
Steward Partners Investment Advisory, LLC29KShares$137,1700.0% of portfolio
-
Two Sigma Securities, LLC New York, NY23.5KShares$111,2250.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.2KShares$71,8430.0% of portfolio
-
Jane Street Group, LLC New York, NY14.6KShares$68,8640.0% of portfolio
About MAINZ BIOMED N.V.
- Ticker MYNZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 14,483,000
- Market Cap $68.5M
- Description
- Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...